Diagnostic and therapeutic problems in heart failure

Area of Science:

• Cardiology
• Internal Medicine

Background:

• Heart failure (HF) affects a growing population, presenting complex diagnostic, therapeutic, and socioeconomic challenges.
• Despite advances, HF prognosis remains poor due to incompletely understood pathophysiology and suboptimal current treatments.
• Historically, research focused on advanced HF, yielding disappointing results; current emphasis shifts towards prevention.

Purpose of the Study:

• To review current understanding and approaches to heart failure management.
• To highlight the importance of prevention and early treatment goals in improving patient outcomes.
• To discuss pharmacological and electrotherapeutic interventions for heart failure.

Main Methods:

• Review of existing literature on heart failure pathophysiology, diagnosis, and treatment.
• Analysis of current therapeutic strategies, including medications and devices.
• Discussion of healthcare models for heart failure patient management.

Main Results:

• Pharmacological agents like beta-blockers, ACE inhibitors, ARBs, and aldosterone antagonists reduce mortality.
• Diuretics, digoxin, and inotropes help manage HF symptoms, with therapy intensity guided by NYHA class.
• Advanced HF patient outcomes have improved with electrotherapy, such as cardioverter-defibrillators and resynchronization devices.

Conclusions:

• Effective HF management requires prioritizing prevention and early intervention.
• A unified, outpatient-focused healthcare model is crucial for optimal HF patient care.
• Continued research into HF pathophysiology is essential for developing more effective treatments.